,address1,address2,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Mr. Joseph  Todisco MBA', 'age': 46, 'title': 'CEO & Director', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 927625, 'exercisedValue': 0, 'unexercisedValue': 0}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
1,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Dr. Matthew T. David M.D.', 'age': 44, 'title': 'Exec. VP & CFO', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 830644, 'exercisedValue': 0, 'unexercisedValue': 13663}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
2,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Dr. Phoebe  Mounts Esq., Ph.D.', 'age': 71, 'title': 'EVP, Gen. Counsel, Head of Regulatory, Compliance & Legal and Sec.', 'yearBorn': 1951, 'fiscalYear': 2022, 'totalPay': 582221, 'exercisedValue': 0, 'unexercisedValue': 11900}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
3,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Ms. Elizabeth  Masson-Hurlburt B.A.', 'age': 43, 'title': 'Exec. VP and Head of Clinical & Medical Affairs', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 538911, 'exercisedValue': 0, 'unexercisedValue': 158268}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
4,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Donna  Ucci', 'title': 'Sr. VP & Head of Global Quality', 'exercisedValue': 0, 'unexercisedValue': 0}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
5,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Dr. Tushar  Mukherjee', 'title': 'Sr. VP & Head of Technical Operations', 'exercisedValue': 0, 'unexercisedValue': 0}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
6,300 Connell Drive,Suite 4200,Berkeley Heights,NJ,07922,United States,908 517 9500,908 375 8272,https://www.cormedix.com,Biotechnology,Healthcare,"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.",40,"{'maxAge': 1, 'name': 'Ms. Erin  Mistry', 'age': 40, 'title': 'Exec. VP & Chief Commercial Officer', 'yearBorn': 1982, 'exercisedValue': 0, 'unexercisedValue': 0}",6,5,7,1,4,1693526400,1672444800,86400,4,3.97,3.98,3.835,4.0,3.97,3.98,3.835,4.0,0.0,1.84751,-5.5070424,1443635,1443635,793074,629210,629210,3.87,4.08,1800,1000,214314928,2.71,6.09,5868.587,4.0476,4.3349,0.0,0.0,USD,162539920,0.0,54140933,54812000,4040540,4360385,1690761600,1693440000,0.073699996,0.00855,0.21099001,9.77,0.074200004,1.071,3.6507938,1672444800,1703980800,1688083200,-36903516,-0.84,-0.71,1:5,1553558400,4450.832,-4.267,NGM,EQUITY,CRMD,CRMD,CorMedix Inc.,CorMedix Inc.,1273757400,America/New_York,EDT,-14400000,3.91,19.0,6.0,13.75,15.0,2.0,buy,4,52400776,0.957,-38094832,736855,7.093,7.394,36519,1.502,0.001,-0.3824,-0.66619,61674,-18282476,-31116592,0.94865996,0.0,-1045.2894,USD,
